You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Drug Price Trends for NDC 74157-0016


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 74157-0016

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Diclofenac Potassium (NDC: 74157-0016)

Diclofenac potassium, identified by the National Drug Code (NDC) 74157-0016, is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. As we delve into the market analysis and price projections for this medication, we'll explore various factors influencing its pricing, market trends, and future outlook.

Understanding Diclofenac Potassium

Diclofenac potassium is a benzeneacetic acid derivative, chemically designated as 2-[(2,6-dichlorophenyl) amino] benzeneacetic acid, monopotassium salt[1]. It's commonly used to treat mild to moderate pain and inflammation associated with various conditions.

Therapeutic Uses

This NSAID is prescribed for a range of conditions, including:

  • Muscle aches
  • Arthritis pain
  • Menstrual cramps
  • Headaches
  • Toothaches

Formulation and Packaging

The specific NDC 74157-0016 refers to a coated tablet form of diclofenac potassium. It's packaged by INA Pharmaceutics Inc and falls under the category of human prescription drugs[1].

Current Market Landscape

The pharmaceutical market is a complex ecosystem influenced by numerous factors. Let's break down the current landscape for diclofenac potassium.

Generic vs. Brand-Name Dynamics

Diclofenac potassium is available as both a generic and brand-name drug. Generic versions typically have more stable pricing due to competition among multiple manufacturers. This competition generally keeps prices in check and benefits consumers.

The median price increase for generic drugs has been around 19.9%, although this can vary widely depending on the specific drug and market conditions[2].

Regulatory Environment

The regulatory landscape plays a crucial role in drug pricing and availability. The FDA's oversight ensures quality and safety but also impacts market dynamics. For instance, the FDA's National Drug Code Directory contains information about finished drug products, unfinished drugs, and compounded drug products[5].

Market Competition

The presence of multiple generic manufacturers for diclofenac potassium ensures a competitive market. This competition is generally beneficial for maintaining reasonable prices and ensuring supply stability.

Factors Influencing Pricing

Several key factors influence the pricing of diclofenac potassium:

Raw Material Costs

The cost of raw materials used in manufacturing diclofenac potassium can significantly impact its final price. Fluctuations in these costs can lead to price adjustments.

Manufacturing Efficiencies

Advancements in manufacturing processes can lead to cost savings, potentially resulting in lower prices or increased profit margins for manufacturers.

Supply Chain Resilience

The pharmaceutical industry is focusing on optimizing supply chains for sustainability and resilience. More than 85% of biopharma executives are investing in data, AI, and digital tools to build supply chain resiliency[9].

Regulatory Changes

Any significant regulatory changes, such as new reporting requirements or upper payment limits, could impact pricing strategies for both generic and brand-name versions of diclofenac potassium.

Market Trends and Projections

Short-Term Outlook

In the short term, we can expect relative stability in the pricing of diclofenac potassium. The competitive nature of the generic drug market typically prevents dramatic price fluctuations.

Long-Term Projections

Looking ahead, several factors could influence the long-term pricing and market position of diclofenac potassium:

  1. Technological Advancements: Innovations in drug development and manufacturing could lead to efficiencies that might stabilize or reduce prices.

  2. Emerging Markets: Pharmaceutical companies are focusing on self-sufficiency and growing their footprint in emerging markets primed for growth[9].

  3. AI and Data-Driven Strategies: The industry is heavily investing in data and AI to foster innovation and reduce drug development costs and timelines[9].

Impact of Industry Trends on Diclofenac Potassium

R&D Acceleration

The pharmaceutical industry's focus on accelerating R&D through data, AI, and patient-centric trials could potentially lead to improved formulations or delivery methods for diclofenac potassium in the future.

Supply Chain Optimization

As companies invest in smart manufacturing and supply chain resilience, we might see more stable supply and potentially lower production costs for drugs like diclofenac potassium.

Evolving Portfolio Strategies

Many pharmaceutical companies are evolving their portfolios based on scientific and technological breakthroughs. While diclofenac potassium is an established drug, its market position could be influenced by the introduction of new pain management therapies.

Comparative Analysis

To better understand the market position of diclofenac potassium, let's compare it with other NSAIDs:

Drug Market Position Price Trend
Diclofenac Potassium Established generic Relatively stable
Ibuprofen Widely available OTC Low-cost
Naproxen Popular prescription and OTC Moderate
Celecoxib Prescription only, some patent protection Higher-priced

This comparison highlights the competitive landscape in which diclofenac potassium operates, emphasizing its position as an established generic option.

Future Market Dynamics

Potential Disruptors

  1. Novel Pain Management Therapies: Emerging treatments could potentially impact the market share of traditional NSAIDs like diclofenac potassium.

  2. Regulatory Changes: Any significant shifts in healthcare policy or drug pricing regulations could affect the market dynamics.

  3. Consumer Trends: Increasing focus on natural or alternative pain management solutions might influence demand for pharmaceutical options.

Opportunities for Growth

Despite potential challenges, there are opportunities for growth in the diclofenac potassium market:

  1. Emerging Markets: Expanding access in developing countries could open new revenue streams.

  2. Formulation Innovations: Development of new delivery methods or combination therapies could enhance the drug's appeal.

  3. Digital Health Integration: Incorporating diclofenac potassium into digital health solutions for pain management could create new market niches.

Price Projection Scenarios

Based on the factors discussed, we can outline three potential pricing scenarios for diclofenac potassium:

  1. Stable Pricing: The most likely scenario, where prices remain relatively constant due to market competition and established manufacturing processes.

  2. Moderate Increase: A scenario where factors like raw material costs or regulatory changes lead to a gradual increase in prices.

  3. Slight Decrease: An optimistic scenario where manufacturing efficiencies and increased competition lead to modest price reductions.

Key Takeaways

  • Diclofenac potassium (NDC: 74157-0016) is a widely used NSAID with a stable market position.
  • The generic nature of the drug contributes to price stability and market competitiveness.
  • Industry trends like AI integration and supply chain optimization may influence future pricing and availability.
  • Short-term price projections suggest stability, while long-term outlook depends on various factors including technological advancements and regulatory changes.
  • The drug's future market position may be influenced by emerging pain management therapies and evolving consumer preferences.

FAQs

  1. Q: How does the pricing of diclofenac potassium compare to other NSAIDs? A: Diclofenac potassium, as a generic drug, is generally competitively priced compared to other NSAIDs. Its pricing is typically more stable than brand-name alternatives but may be higher than some over-the-counter options like ibuprofen.

  2. Q: What factors could lead to a price increase for diclofenac potassium? A: Potential factors include increases in raw material costs, changes in regulatory requirements, supply chain disruptions, or a decrease in the number of manufacturers producing the drug.

  3. Q: How might technological advancements impact the production and pricing of diclofenac potassium? A: Technological advancements, particularly in manufacturing processes, could lead to increased efficiency and potentially lower production costs. This could result in price stability or even slight decreases in the long term.

  4. Q: Are there any upcoming patent expirations that could affect the market for diclofenac potassium? A: As diclofenac potassium is already available as a generic drug, there are no significant patent expirations that would directly impact its market. However, patent expirations for other pain medications could indirectly affect market dynamics.

  5. Q: How might the focus on personalized medicine affect drugs like diclofenac potassium? A: While personalized medicine is a growing trend, it's less likely to directly impact widely used generic drugs like diclofenac potassium. However, it could lead to the development of more targeted pain management therapies that might compete with traditional NSAIDs in certain patient populations.

Sources cited: [1] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecd99fe-cb74-4a65-9636-2aefd2416ece [2] https://www.drugpatentwatch.com/p/drug-price/ndc/00378-0167 [5] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [9] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.